Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT00002465
What this trial is testing

High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

Who this might be right for
Breast CancerEndometrial CancerMalignant Mesothelioma
St. Vincent Medical Center - Los Angeles
Testing effectiveness (Phase 2)Active Not RecruitingNCT02414269
What this trial is testing

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Who this might be right for
Malignant Pleural DiseaseMesotheliomaMetastases+2 more
Memorial Sloan Kettering Cancer Center 113
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT02716272
What this trial is testing

Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 125
Testing effectiveness (Phase 2)Study completedNCT00700336
What this trial is testing

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

Who this might be right for
Malignant Pleural MesotheliomaSolid Tumors
CanBas Co. Ltd. 69
Testing effectiveness (Phase 2)Study completedNCT01243632
What this trial is testing

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

Who this might be right for
Malignant Pleural Mesothelioma
Institute of Oncology Ljubljana 78